SKIN The Journal of Cutaneous Medicine

Efficacy and Safety of a Novel Tazarotene 0.045% Lotion in Females and Males with Moderate-to-Severe Acne

H Baldwin, L Green, L Kircik, E Guenin

Page S15

Poster PDF

Real World Patient Perceptions of the use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris

James Q Del Rosso, Corey L Hartman, Caitlin Lewis, Rhonda Schreiber

Page S4

Poster PDF

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

Z Draelos, F Cook-Bolden, L Green, E Guenin, G Martin, R Pillai

Page S19

Poster PDF

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

Zoe Draelos, Fran Cook-Bolden, Lawrence Green, Eric Guenin, Gina Martin, Radhakrishnan Pillai

Page S9

Poster PDF

Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials

Rhonda Schreiber, Kaytiana Crane, Juhin Patel

Page s50

Poster PDF

Patient Assessment of Foam Attributes from the Tazarotene Foam, 0.1%, Phase III Trials and Potential Impact on Patient Compliance

Rhonda Schreiber, Caitlin Lewis, Kaytiana Crane

Page S57

Poster PDF

Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Acne Patients with Oily Skin

Emil Tanghetti, Michael Gold, Neil Sadick, Fran Cook-Bolden, Leon Kircik, Linda Stein Gold, Stephen Tyring, James Del Rosso, Eric Guenin

Page s71

Poster PDF

Tazarotene 0.045% Lotion for Acne: Formulation, Application Characteristics, and Clinical Efficacy and Safety

Zoe Draelos, Emil Tanghetti, Linda Stein Gold, Hilary Baldwin, Leon Kircik, Eric Guenin

Page s69

Poster PDF

Efficacy and Safety of Tazarotene 0.045% Lotion in White Adults with Moderate-to-Severe Acne

James Del Rosso, Linda Stein Gold, Stephen Tyring, William Philip Werschler, Fran Cook-Bolden, George Han, Neal Bhatia, Eric Guenin

Page s70

Poster PDF

Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Different Adult Age Groups

Neil Sadick, Fran Cook-Bolden, Kenneth Beer, Zoe Draelos, Leon Kircik, Emil Tanghetti, Eric Guenin

Page s18

Poster PDF

Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data

Jonette Keri, Leon Kircik, Lawrence Green, Glynis Ablon, William Werschler, Emil Tanghetti, Zoe Draelos, Eric Guenin

Page s12

Poster PDF

Efficacy and Safety of Tazarotene 0.045% Lotion in Female Patients with Moderate-to-Severe Acne: Post Hoc Analysis by Age

Linda Stein Gold, Hilary Baldwin, Fran Cook-Bolden, Lawrence Green, Glynis Ablon, Neil Sadick, Jonathan Weiss, Eric Guenin

Page s23

Poster PDF

Efficacy and Safety of a Novel Tazarotene 0.045% Lotion in Females and Males With Moderate-to-Severe Acne

Hilary E Baldwin, Lawrence Green, Leon Kircik, Ashlie M Caronia, Eric Guenin

Page s60

Poster PDF

Real World Patient Perceptions of the use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris

James Q Del Rosso, Corey L Hartman, Caitlin Lewis, Rhonda Schreiber

Page s58

Poster PDF

Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race

Fran E Cook-Bolden, Neal Bhatia, Jonathan S Weiss, Neil Sadick, Stephen K Tyring, Eric Guenin, Anya Loncaric, Susan Harris

Page s88

Poster PDF

Search

Search Results